Nisa Investment Advisors
IRWD icon

Nisa Investment Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Nisa Investment Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.71K Hold
1,627
– – ﹤0.01% 2424
2025
Q4 		$5.48K Hold
1,627
– – ﹤0.01% 2437
2025
Q3 		$2.13K Sell
1,627
-424
-21% -$439 ﹤0.01% 2606
2025
Q2 		$1.47K Sell
2,051
-367
-15% -$288 ﹤0.01% 2663
2025
Q1 		$3.55K Buy
2,418
+918
+61% +$2.19K ﹤0.01% 2326
2024
Q4 		$6.64K Sell
1,500
-709
-32% -$2.88K ﹤0.01% 2218
2024
Q3 		$9.1K Buy
2,209
+799
+57% +$4.3K ﹤0.01% 2111
2024
Q2 		$9.19K Sell
1,410
-90
-6% -$637 ﹤0.01% 2178
2024
Q1 		$13.1K Buy
1,500
+125
+9% +$1.52K ﹤0.01% 1991
2023
Q4 		$15.7K Hold
1,375
– – ﹤0.01% 1937
2023
Q3 		$13.2K Sell
1,375
-2,520
-65% -$24.7K ﹤0.01% 2117
2023
Q2 		$41.4K Buy
3,895
+1,112
+40% +$12K ﹤0.01% 1812
2023
Q1 		$29K Sell
2,783
-3,856
-58% -$43.2K ﹤0.01% 1888
2022
Q4 		$82K Hold
6,639
– – ﹤0.01% 1622
2022
Q3 		$73K Buy
6,639
+99
+2% +$1.12K ﹤0.01% 1609
2022
Q2 		$75K Hold
6,540
– – ﹤0.01% 1590
2022
Q1 		$82K Sell
6,540
-580
-8% -$6.65K ﹤0.01% 1691
2021
Q4 		$79K Sell
7,120
-1,210
-15% -$14.8K ﹤0.01% 1602
2021
Q3 		$109 Hold
8,330
– – ﹤0.01% 1660
2021
Q2 		$107 Hold
8,330
– – ﹤0.01% 1655
2021
Q1 		$93 Hold
8,330
– – ﹤0.01% 1779
2020
Q4 		$95K Buy
8,330
+1,500
+22% +$16.4K ﹤0.01% 1750
2020
Q3 		$61K Buy
6,830
+5,650
+479% +$56.2K ﹤0.01% 1721
2020
Q2 		$12K Hold
1,180
– – ﹤0.01% 1884
2020
Q1 		$12K Sell
1,180
-5,630
-83% -$66.2K ﹤0.01% 1817
2019
Q4 		$91K Hold
6,810
– – ﹤0.01% 1454
2019
Q3 		$58K Hold
6,810
– – ﹤0.01% 1521
2019
Q2 		$75K Sell
6,810
-1,321
-16% -$14.8K ﹤0.01% 1459
2019
Q1 		$92K Hold
8,131
– – ﹤0.01% 1447
2018
Q4 		$71K Hold
8,131
– – ﹤0.01% 1415
2018
Q3 		$126K Hold
8,131
– – ﹤0.01% 1377
2018
Q2 		$130K Hold
8,131
– – ﹤0.01% 1331
2018
Q1 		$105K Sell
8,131
-179
-2% -$2.23K ﹤0.01% 1345
2017
Q4 		$104K Hold
8,310
– – ﹤0.01% 1371
2017
Q3 		$110K Hold
8,310
– – ﹤0.01% 1355
2017
Q2 		$131K Hold
8,310
– – ﹤0.01% 1316
2017
Q1 		$119K Sell
8,310
-1,003
-11% -$13.7K ﹤0.01% 1336
2016
Q4 		$119K Sell
9,313
-8,836
-49% -$112K ﹤0.01% 1320
2016
Q3 		$241K Hold
18,149
– – ﹤0.01% 1181
2016
Q2 		$199K Hold
18,149
– – ﹤0.01% 1215
2016
Q1 		$166K Buy
+18,149
New +$150K ﹤0.01% 1263

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nisa Investment Advisors's IRWD Position: Q1 2026 in Review

Nisa Investment Advisors held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 1,627 shares worth $5.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2424.

Nisa Investment Advisors first reported a position in IRWD in Q1 2016 and has held it in 41 quarters since. The position peaked at $241K in Q3 2016. 227 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Nisa Investment Advisors held 1,627 shares of Ironwood Pharmaceuticals worth $5.71K as of Q1 2026.
  • Nisa Investment Advisors left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2424 holding.
  • Nisa Investment Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2016 and has held it in 41 quarters since.
  • Nisa Investment Advisors's Ironwood Pharmaceuticals position peaked at $241K in Q3 2016.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.